Skip to main content

Want a detailed portfolio tracker?

Virax Biolabs Group (VRAX) P/E (2022 - 2026)

Virax Biolabs Group (VRAX) P/E from Jul 21, 2022 to Jul 20, 2026. The TTM Virax Biolabs Group (VRAX) P/E is -1.01. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Virax Biolabs Group (VRAX)

YearP/EChange
2026-1.01-55.00%
2025-2.25-72.76%
2024-8.25+81.64%
2023-4.54-92.50%
2022-60.62N/A

Comparison Virax Biolabs Group (VRAX) P/E with competitors

Virax Biolabs Group (VRAX) P/E is -1.01.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.17%
NBYStablecoin Development Corp0.00-100.43%
ENLVEnlivex Ltd0.07-107.39%
FGENFibroGen Inc0.24-123.73%
CHRSCoherus Biosciences Inc0.85-183.87%
FBIOFortress Biotech Inc0.95-193.81%
ORMPOramed Pharmaceuticals Inc1.50-248.57%
AGENAgenus Inc3.01-397.48%
INVAInnoviva Inc3.15-411.76%
VXRTVaxart Inc3.55-450.87%
CRMDCorMedix Inc3.63-458.65%
CVACCureVac N.V.4.45-539.43%
GLPGGalapagos NV4.86-580.27%
SRPTSarepta Therapeutics Inc4.88-582.57%
ABEOAbeona Therapeutics Inc5.39-632.53%
ABUSArbutus Biopharma Corp5.60-653.10%
ZVRAZevra Therapeutics Inc5.89-681.92%
SPROSpero Therapeutics Inc6.23-715.65%
CGENCompugen Ltd6.31-724.10%
RIGLRigel Pharmaceuticals6.87-779.27%
SLXNSilexion Therapeutics Corp7.30-821.18%
OMEROmeros Corporation9.26-1015.18%
AUPHAurinia Pharmaceuticals Inc9.58-1047.42%
PLXProtalix BioTherapeutics Inc10.89-1176.52%
ACADAcadia Pharmaceuticals Inc11.73-1259.30%
TBPHTheravance Biopharma Inc12.26-1312.05%
ADMAAdma Biologics Inc12.42-1327.47%
HRMYHarmony Biosciences Holdings Inc13.82-1466.05%
SABSSAB Biotherapeutics Inc14.14-1497.29%
NAGENiagen Bioscience Inc14.82-1564.69%
INCYIncyte Corp15.82-1663.98%
REGNRegeneron Pharmaceuticals Inc15.86-1667.35%
PBYIPuma Biotechnology Inc17.32-1811.57%
CPRXCatalyst Pharmaceuticals Inc17.44-1823.78%
EXELExelixis Inc17.54-1833.54%
TGTXTG Therapeutics Inc18.97-1974.70%
MDXGMimedx Group Inc20.55-2131.51%
XOMAXOMA Royalty Corp22.87-2361.10%
ARGXArgen X SE24.30-2501.79%
CTMXCytomX Therapeutics Inc24.82-2553.50%
XOMAOXOMA Royalty Corp25.34-2605.27%
HALOHalozyme Therapeutics Inc25.62-2632.84%
XOMAPXOMA Royalty Corp25.67-2637.42%
VRTXVertex Pharmaceuticals Inc27.99-2867.21%
RPRXRoyalty Pharma plc - Class A28.69-2935.69%
SLNOSoleno Therapeutics Inc29.02-2968.09%
ASNDAscendis Pharma A/S30.09-3073.88%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3847.50%
APLSApellis Pharmaceuticals Inc39.02-3957.15%
BMRNBiomarin Pharmaceutical Inc42.21-4272.53%
KRYSKrystal Biotech Inc45.34-4582.09%
ONCBeiGene Ltd69.54-6973.90%
PHARPharming Group N.V.75.03-7516.09%
TECHBio-Techne Corp101.96-10178.33%
VCELVericel Corp109.92-10965.45%
ALNYAlnylam Pharmaceuticals Inc117.96-11760.55%
GMABGenmab140.29-13967.39%
TLXTelix Pharmaceuticals Ltd162.15-16128.40%
CORTCorcept Therapeutics Inc212.86-21140.43%